US Stock MarketDetailed Quotes

MBX MBX Biosciences

Watchlist
  • 19.830
  • +0.440+2.27%
Close Nov 26 16:00 ET
  • 19.830
  • 0.0000.00%
Post 16:00 ET
662.67MMarket Cap-11996P/E (TTM)

MBX Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(FY)Dec 31, 2022
Total revenue
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
79.19%19.61M
40.34%35.31M
9.99M
10.95M
25.16M
Selling and administrative expenses
53.04%2.87M
80.05%6.78M
--2.26M
--1.87M
--3.76M
-General and administrative expense
53.04%2.87M
80.05%6.78M
--2.26M
--1.87M
--3.76M
Research and development costs
84.58%16.75M
33.36%28.53M
--7.73M
--9.07M
--21.4M
Operating profit
-79.19%-19.61M
-40.34%-35.31M
-9.99M
-10.95M
-25.16M
Net non-operating interest income expense
87.74%1.47M
137,500.00%2.75M
1.15M
783K
-2K
Non-operating interest income
87.74%1.47M
638.71%2.75M
--1.15M
--783K
--372K
Non-operating interest expense
----
--0
----
----
--374K
Other net income (expense)
-972K
Gain on sale of security
----
----
----
----
---73K
Special income (charges)
----
--0
----
----
---899K
-Less:Other special charges
----
----
----
----
--899K
Income before tax
-78.53%-18.14M
-24.60%-32.56M
-8.84M
-10.16M
-26.14M
Income tax
Net income
-78.53%-18.14M
-24.60%-32.56M
-8.84M
-10.16M
-26.14M
Net income continuous Operations
-78.53%-18.14M
-24.60%-32.56M
---8.84M
---10.16M
---26.14M
Minority interest income
Net income attributable to the parent company
-78.53%-18.14M
-24.60%-32.56M
-8.84M
-10.16M
-26.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-78.53%-18.14M
-24.60%-32.56M
-8.84M
-10.16M
-26.14M
Basic earnings per share
-771.42%-2.78
-24.60%-1.0223
-0.2776
-0.319
-0.8205
Diluted earnings per share
-771.42%-2.78
-24.60%-1.0223
-0.2776
-0.319
-0.8205
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
(Q3)Sep 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(FY)Dec 31, 2022
Total revenue 00000
Operating revenue --0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 79.19%19.61M40.34%35.31M9.99M10.95M25.16M
Selling and administrative expenses 53.04%2.87M80.05%6.78M--2.26M--1.87M--3.76M
-General and administrative expense 53.04%2.87M80.05%6.78M--2.26M--1.87M--3.76M
Research and development costs 84.58%16.75M33.36%28.53M--7.73M--9.07M--21.4M
Operating profit -79.19%-19.61M-40.34%-35.31M-9.99M-10.95M-25.16M
Net non-operating interest income expense 87.74%1.47M137,500.00%2.75M1.15M783K-2K
Non-operating interest income 87.74%1.47M638.71%2.75M--1.15M--783K--372K
Non-operating interest expense ------0----------374K
Other net income (expense) -972K
Gain on sale of security -------------------73K
Special income (charges) ------0-----------899K
-Less:Other special charges ------------------899K
Income before tax -78.53%-18.14M-24.60%-32.56M-8.84M-10.16M-26.14M
Income tax
Net income -78.53%-18.14M-24.60%-32.56M-8.84M-10.16M-26.14M
Net income continuous Operations -78.53%-18.14M-24.60%-32.56M---8.84M---10.16M---26.14M
Minority interest income
Net income attributable to the parent company -78.53%-18.14M-24.60%-32.56M-8.84M-10.16M-26.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -78.53%-18.14M-24.60%-32.56M-8.84M-10.16M-26.14M
Basic earnings per share -771.42%-2.78-24.60%-1.0223-0.2776-0.319-0.8205
Diluted earnings per share -771.42%-2.78-24.60%-1.0223-0.2776-0.319-0.8205
Dividend per share
Currency Unit USDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Recent IPOs
Recent IPOs
Intraday+0.28%